Literature DB >> 11931541

Does angiotensin II type 1 receptor blockade offer a clinical advantage to cirrhotics with ascites?

Hiroshi Fukui.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11931541     DOI: 10.1007/s005350200029

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  22 in total

1.  Angiotensin II receptor antagonists in the pharmacological therapy of portal hypertension: a caution.

Authors:  G García-Tsao
Journal:  Gastroenterology       Date:  1999-09       Impact factor: 22.682

Review 2.  Angiotensin receptor blockade and portal hypertension: paradise gained and paradise lost.

Authors:  A J Sanyal
Journal:  Gastroenterology       Date:  2001-08       Impact factor: 22.682

3.  Clinical and hormonal conditions associated with sodium retention in cirrhotic patients with ascites. Evaluation by univariate and multivariate analyses.

Authors:  S Gentile; M Angelico; M G Chiappini; G Peruzzi; S Vulterini
Journal:  Dig Dis Sci       Date:  1987-06       Impact factor: 3.199

4.  The renin-angiotensin-aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance.

Authors:  L Sellars; A C Shore; V Mott; R Wilkinson
Journal:  Q J Med       Date:  1985-08

5.  Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis.

Authors:  J González-Abraldes; A Albillos; R Bañares; L R Del Arbol; E Moitinho; C Rodríguez; M González; A Escorsell; J C García-Pagán; J Bosch
Journal:  Gastroenterology       Date:  2001-08       Impact factor: 22.682

6.  Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension.

Authors:  M Schepke; E Werner; E Biecker; P Schiedermaier; J Heller; M Neef; B Stoffel-Wagner; U Hofer; W H Caselmann; T Sauerbruch
Journal:  Gastroenterology       Date:  2001-08       Impact factor: 22.682

7.  One-week losartan administration increases sodium excretion in cirrhotic patients with and without ascites.

Authors:  Ying-Ying Yang; Han-Chieh Lin; Wui-Chiang Lee; Ming-Chih Hou; Fa-Yauh Lee; Full-Young Chang; Shou-Dong Lee
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

8.  Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis.

Authors:  A A van Vliet; W H Hackeng; A J Donker; S G Meuwissen
Journal:  J Hepatol       Date:  1992-05       Impact factor: 25.083

9.  Renal response to a saline load in well-compensated alcoholic cirrhosis.

Authors:  F Wong; D Massie; P Hsu; F Dudley
Journal:  Hepatology       Date:  1994-10       Impact factor: 17.425

10.  Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis.

Authors:  A W Schneider; J F Kalk; C P Klein
Journal:  Hepatology       Date:  1999-02       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.